Australia markets open in 2 hours 39 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
50.71+0.40 (+0.79%)
As of 03:21PM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
44,935,000
46,159,000
46,385,000
42,518,000
26,145,000
Cost of revenue
10,541,000
10,137,000
9,940,000
11,773,000
8,078,000
Gross profit
34,394,000
36,022,000
36,445,000
30,745,000
18,067,000
Operating expenses
Research development
9,331,000
9,509,000
10,195,000
11,143,000
6,148,000
Selling general and administrative
7,965,000
7,814,000
7,690,000
7,661,000
4,871,000
Total operating expenses
26,408,000
26,918,000
27,908,000
28,568,000
12,154,000
Operating income or loss
7,986,000
9,104,000
8,537,000
2,177,000
5,913,000
Interest expense
1,144,000
1,232,000
1,334,000
1,420,000
656,000
Total other income/expenses net
1,783,000
-159,000
-559,000
-7,628,000
-282,000
Income before tax
8,625,000
7,713,000
8,098,000
-6,871,000
4,975,000
Income tax expense
322,000
1,368,000
1,084,000
2,124,000
1,515,000
Income from continuing operations
8,303,000
6,345,000
7,014,000
-8,995,000
3,460,000
Net income
8,285,000
6,327,000
6,994,000
-9,015,000
3,439,000
Net income available to common shareholders
8,285,000
6,327,000
6,994,000
-9,015,000
3,439,000
Basic EPS
3.97
2.97
3.25
-3.99
2.02
Diluted EPS
3.94
2.95
3.12
-3.99
2.01
Basic average shares
2,089,500
2,130,000
2,153,000
2,258,000
1,705,000
Diluted average shares
2,100,250
2,146,000
2,245,000
2,258,000
1,712,000